Detalles de la búsqueda
1.
Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial.
Crit Care;
27(1): 226, 2023 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37291677
2.
Immunomodulation and endothelial barrier protection mediate the association between oral imatinib and mortality in hospitalised COVID-19 patients.
Eur Respir J;
60(6)2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35896211
3.
Cardiac Safety of Imatinib for the Treatment of COVID-19: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial.
J Cardiovasc Pharmacol;
80(6): 783-791, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35976136
4.
The diagnostic accuracy of lung ultrasound to determine PiCCO-derived extravascular lung water in invasively ventilated patients with COVID-19 ARDS.
Ultrasound J;
15(1): 40, 2023 Oct 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37782370
5.
The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19.
Trials;
23(1): 158, 2022 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172891
6.
Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.
Lancet Respir Med;
9(9): 957-968, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34147142
7.
Long-term clinical outcomes of COVID-19 patients treated with imatinib.
Lancet Respir Med;
10(4): e34-e35, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35183270
Resultados
1 -
7
de 7
1
Próxima >
>>